Skip to main content

Aktis Oncology, Inc.

AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002035832

In the last 90 days, Aktis Oncology, Inc. insiders filed 0 open-market purchases and 1 sale; 124 institutions reported holding it in 13F filings for Q3 2026, worth $716.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Aktis Oncology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $258.6K in total
Insiders trading
1
Net value
−$258.6K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Aktis Oncology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Aktis Oncology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Feldman Paul LChief Scientific Officer199,603Nov 19, 20261
Czibere AkosChief Medical Officer0Sep 24, 20262
Herrmann KenDirector0Jul 21, 20262
Ron-Bigger ShulamitChief Operating Officer0Jul 10, 20261
Gormley GlennDirector–Apr 16, 20261
Evnin Luke10% Owner10,260,064IndirectJan 14, 20261
MPM Oncology Innovations Fund LP10% Owner10,260,064IndirectJan 14, 20261
MPM Bioventures 2018 (B), L.P.10% Owner10,260,064IndirectJan 14, 20261
MPM Bioventures 2018, L.P.10% Owner10,260,064IndirectJan 14, 20261
MPM Asset Management Investors BV2018 LLC10% Owner10,260,064IndirectJan 14, 20261
MPM BioVentures 2018 GP LLC10% Owner10,260,064IndirectJan 14, 20261
MPM BioVentures 2018 LLC10% Owner10,260,064IndirectJan 14, 20261
MPM Oncology Innovations Fund GP LLC10% Owner10,260,064IndirectJan 14, 20261
Gadicke Ansbert10% Owner10,260,064IndirectJan 14, 20261
MPM Asset Management LLC10% Owner10,260,064IndirectJan 14, 20261
Oncology Impact Private Investment Fund 2, L.P.10% Owner10,260,064IndirectJan 14, 20261
Foley ToddDirector, 10% Owner4,235,403IndirectJan 14, 20261
Nodelman OlegDirector347,305IndirectJan 12, 20261
EcoR1 Capital, LLCDirector347,305IndirectJan 12, 20261
Vida Ventures II, LLC10% Owner157,387IndirectJan 12, 20261
Vida Ventures II-A, LLC10% Owner157,387IndirectJan 12, 20261
Kim Helen SusanDirector, 10% Owner157,387IndirectJan 12, 20261
Segal Lloyd MitchellDirector19,631IndirectJan 12, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)4:05 PM ETSep 231 dayCzibere AkosChief Medical OfficerSSale−12.5K$20.69−$258.6K−100.0%0 after2 lots10b5-1
Jul 21, 2026 (view filing)8:50 PM ETJul 201 dayHerrmann KenDirectorSSale−4.86K$24.56−$119.3K−100.0%0 after2 lots
Jul 20, 2026 (view filing)5:34 PM ETJul 173 daysHerrmann KenDirectorSSale−3.06K$25.21−$77.3K−100.0%0 after
Jul 10, 2026 (view filing)6:11 AM ETJul 82 daysRon-Bigger ShulamitChief Operating OfficerSSale−50.0K$27.75−$1.39M−100.0%0 after3 lots
Jul 10, 2026 (view filing)6:10 AM ETJul 82 daysCzibere AkosChief Medical OfficerSSale−50.0K$27.77−$1.39M−100.0%0 after3 lots
Jan 14, 2026 (view filing)6:19 PM ETJan 122 daysEvnin Luke and 7 others10% OwnerPPurchase+1.11M$18.00+$20.0M+12.2%10.3M afterDuplicate filing
Jan 14, 2026 (view filing)6:17 PM ETJan 122 daysGadicke Ansbert and 2 others10% OwnerPPurchase+1.11M$18.00+$20.0M+12.2%10.3M after
Jan 14, 2026 (view filing)Jan 122 daysFoley ToddDirector, 10% OwnerPPurchase+232.9K$18.00+$4.19M+5.8%4.24M after
Jan 12, 2026 (view filing)8:28 PM ETJan 12Same dayNodelman Oleg and 1 otherDirectorPPurchase+2.22M$18.00+$40.0MNew position347.3K after2 lots
Jan 12, 2026 (view filing)5:10 PM ETJan 12Same dayVida Ventures II, LLC and 1 other10% OwnerPPurchase+835.0K$18.00+$15.0MNew position157.4K after2 lotsDuplicate filing
Jan 12, 2026 (view filing)Jan 12Same dayKim Helen SusanDirector, 10% OwnerPPurchase+835.0K$18.00+$15.0MNew position157.4K after2 lots